Your browser doesn't support javascript.
loading
Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways.
Li, Hefei; Zhang, Yushan; Lan, Xiaomei; Yu, Jianhua; Yang, Changshuang; Sun, Zhijian; Kang, Ping; Han, Yi; Yu, Daping.
Affiliation
  • Li H; Department of Thoracic Surgery, Affiliated Hospital of Hebei University, Baoding, China.
  • Zhang Y; Department of Thoracic Surgery, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
  • Lan X; K2 Oncology Co. Ltd., Beijing, China.
  • Yu J; Oncology Department, Wang Jing Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • Yang C; K2 Oncology Co. Ltd., Beijing, China.
  • Sun Z; K2 Oncology Co. Ltd., Beijing, China.
  • Kang P; K2 Oncology Co. Ltd., Beijing, China.
  • Han Y; Department of Thoracic Surgery, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
  • Yu D; Department of Thoracic Surgery, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Front Cell Dev Biol ; 9: 773048, 2021.
Article in En | MEDLINE | ID: mdl-34901018
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Cell Dev Biol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Cell Dev Biol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland